Drug Information

Drug General Information
Drug ID
D0S8DU
Former ID
DNCL003061
Drug Name
TGWOOAA
Indication Generalized anxiety disorder; Social phobia [ICD9: 300, 300.02, 300.23; ICD10:F40-F42, F40.1, F41.1, F93.2] Phase 2 [550646]
Company
Fabre-Kramer Pharmaceuticals
Target and Pathway
Target(s) 5-HT 2 receptor Target Info Antagonist [550645]
5-hydroxytryptamine 1A receptor Target Info Antagonist [550645]
KEGG Pathway Calcium signaling pathway
Neuroactive ligand-receptor interaction
Gap junction
Serotonergic synapse
Inflammatory mediator regulation of TRP channelshsa04024:cAMP signaling pathway
PANTHER Pathway Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
5HT1 type receptor mediated signaling pathway
Reactome Serotonin receptors
G alpha (i) signalling events
WikiPathways Serotonin HTR1 Group and FOS Pathway
SIDS Susceptibility Pathways
Monoamine GPCRs
GPCRs, Class A Rhodopsin-like
GPCR ligand binding
GPCR downstream signaling
References
Ref 550646Clinical pipeline report, company report or official report of Fabre-Kramer Pharmaceuticals.
Ref 550645Clinical pipeline report, company report or official report of Fabre-Kramer Pharmaceuticals.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.